510(k) Report

510(k) · Cleared

Cleared

Combi 8 Max

K070888510(k) AbbreviatedCleared Jul 3, 2008461-day reviewClass II21 CFR 890.5850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cec Electronica S.R.L. · IPF Stimulator, Muscle, Powered

Cleared on Jul 3, 2008 as substantially equivalent to K984114 (Mettler Electronics Corp., 1999) and 2 other predicates after a 461-day review. Its family tree reaches back 2 generations to 1995. 2 later devices descend from it.

Decided
Jul 3, 2008
Review
461 days
Class
Class II
Product code
IPF
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K945509 (1995). 5 ancestors in all. 2 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1999: 1 other ancestor1996: 1 other ancestor1995: 1 other ancestor2013: 1 descendant cleared2015: 1 descendant clearedK945509 · FX-2 NMS (2CHANNEL Table Model) · Fx-2 · 1995K062354 · Vectra Genisys VMS FR · Encore Medical L.P. · 20071995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 1 descendant K062354 · Vectra Genisys VMS FR · Encore Medical L.P. · 2007K945509 · FX-2 NMS (2CHANNEL Table Model) · Fx-2 · 19950
  1. Root · 2 generations backK945509 FX-2 NMS (2CHANNEL Table Model)Fx-2 · 1995
  2. 1 generation backK062354 Vectra Genisys VMS FREncore Medical L.P. · 2007
  3. This deviceK070888 Combi 8 MaxCec Electronica S.R.L. · 2008
  4. Descendant · cites it directly · 1 of its ownK123642 Muscle Stimulation SystemNiveus Medical, Inc. · 2013
  5. Descendant · 2 generations on · 0 of its ownK150742 Muscle Stimulation System 110Niveus Medical, Inc. · 2015

Most influential descendants

Showing 2 of 2 · See all
  • K123642Muscle Stimulation SystemNiveus Medical, Inc. · 2013 · cites it directly1descendant
  • K150742Muscle Stimulation System 110Niveus Medical, Inc. · 2015 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K945509FX-2 NMS (2CHANNEL Table Model)Fx-21995—
−1K062354Vectra Genisys VMS FREncore Medical L.P.2007—
0 (this device)K070888Combi 8 MaxCec Electronica S.R.L.2008—
+1K123642Muscle Stimulation SystemNiveus Medical, Inc.2013—
+2K150742Muscle Stimulation System 110Niveus Medical, Inc.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510
199610
199910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
201510
FIG. 1 — Lineage of K070888, 1995–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IPF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IPF device

  1. #1 K241433 EVE Synergy (EVE-20M)score 19.6 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K984114Sys Stim 294, Model ME 294
Summary page 1
…istration Number: to be assigned Information on devices to which substantial equivalence is claimed: ____ 510K # Trade, or propriety ameMnfcue=ls K9841 14 SYS STYM 294 Mettler Electronics Corp. 1 K062354 Vectra Genisys…
Mettler Electronics Corp.1999—
*K062354Vectra Genisys VMS FR
Summary page 1
…laimed: ____ 510K # Trade, or propriety ameMnfcue=ls K9841 14 SYS STYM 294 Mettler Electronics Corp. 1 K062354 Vectra Genisys Chattanooga Group 1 K960969 Galva 5-T…
Encore Medical L.P.2007—
*K960969Galva 5-T
Summary page 1
…YS STYM 294 Mettler Electronics Corp. 1 K062354 Vectra Genisys Chattanooga Group 1 K960969 Galva 5-T Zimmer Elektromnedizin Gmbh 1 Technological characteristics, for each out…
Zimmer Elektromedizin GmbH1996—

Also cleared against K984114: 1 other device →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K123642Muscle Stimulation SystemNiveus Medical, Inc.20131

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 11.7 years on median.
  • None of the 5 ancestors has a recall.
  • Of its descendants, K123642 (Niveus Medical, Inc., 2013) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate K984114.

How does its category compare?

All IPF devices

IPF Stimulator, Muscle, Powered: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · IPF

3in 2025

2007: 82008: 62009: 72010: 42011: 42012: 42013: 102014: 42015: 32016: 72017: 52018: 52019: 42020: 92021: 152022: 72023: 92024: 72025: 32026 (partial year): 3
2007high 15 (2021) · low 3 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IPF

257in 2025

2007: 143 days median2008: 140 days median2009: 216 days median2010: 121 days median2011: 275 days median2012: 269 days median2013: 180 days median2014: 264 days median2015: 43 days median2016: 113 days median2017: 110 days median2018: 73 days median2019: 133 days median2020: 121 days median2021: 98 days median2022: 108 days median2023: 255 days median2024: 201 days median2025: 257 days median2026 (partial year): 206 days median
2007high 275 (2011) · low 43 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IPF

1in 2023

2008: 12011: 12012: 32023: 1
2007high 3 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IPF

8in 2025

2007: 112008: 2132009: 1502010: 142011: 252012: 162013: 62014: 192015: 112016: 82017: 22018: 32019: 102020: 132021: 32022: 42023: 82024: 52025: 8
2007high 213 (2008) · low 2 (2017)2025

MAUDE reports naming product code IPF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078143011
200861401213
200972160150
20104121014
20114275125
20124269316
20131018006
20144264019
2015343011
2016711308
2017511002
201857303
20194133010
20209121013
2021159803
2022710804
2023925518
2024720105
2025325708
202632060—

What is it indicated for?

Depending on device model, and the specific waveform applied - COMBI pulse generators are indicated for the following uses: COMBI 4/8 DIGITAL, COMBI TREND 4/8 * Relaxation of muscle spasms · Prevention or retardation of disuse atrophy · Increasing local blood circulation * Muscle re-education · Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis * Maintaining or increasing range of motion. COMBI 4/8 MAX * Relaxation of muscle…

Read the full statement (124 words)

Depending on device model, and the specific waveform applied - COMBI pulse generators are indicated for the following uses:

COMBI 4/8 DIGITAL, COMBI TREND 4/8

* Relaxation of muscle spasms

· Prevention or retardation of disuse atrophy

· Increasing local blood circulation

* Muscle re-education

· Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis

* Maintaining or increasing range of motion.

COMBI 4/8 MAX

* Relaxation of muscle spasms

· Prevention or retardation of disuse atrophy

· Increasing local blood circulation

· Muscle re-education

· Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis

· Maintaining or increasing range of motion.

For TENS waveform:

· Relief of chronic, intractable pain

· Adjunctive treatment of post surgical or post traumatic acute pain

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K070888: Combi 8 Max.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K070888

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026